1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy (Biologic Therapy)
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Oncology Drugs Market Perspective (2017-2028)
2.2 Oncology Drugs Growth Trends by Region
2.2.1 Oncology Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oncology Drugs Historic Market Size by Region (2017-2022)
2.2.3 Oncology Drugs Forecasted Market Size by Region (2023-2028)
2.3 Oncology Drugs Market Dynamics
2.3.1 Oncology Drugs Industry Trends
2.3.2 Oncology Drugs Market Drivers
2.3.3 Oncology Drugs Market Challenges
2.3.4 Oncology Drugs Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Oncology Drugs Players by Revenue
3.1.1 Global Top Oncology Drugs Players by Revenue (2017-2022)
3.1.2 Global Oncology Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Drugs Revenue
3.4 Global Oncology Drugs Market Concentration Ratio
3.4.1 Global Oncology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Drugs Revenue in 2021
3.5 Oncology Drugs Key Players Head office and Area Served
3.6 Key Players Oncology Drugs Product Solution and Service
3.7 Date of Enter into Oncology Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Oncology Drugs Breakdown Data by Type
4.1 Global Oncology Drugs Historic Market Size by Type (2017-2022)
4.2 Global Oncology Drugs Forecasted Market Size by Type (2023-2028) 5 Oncology Drugs Breakdown Data by Application
5.1 Global Oncology Drugs Historic Market Size by Application (2017-2022)
5.2 Global Oncology Drugs Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Oncology Drugs Market Size (2017-2028)
6.2 North America Oncology Drugs Market Size by Type
6.2.1 North America Oncology Drugs Market Size by Type (2017-2022)
6.2.2 North America Oncology Drugs Market Size by Type (2023-2028)
6.2.3 North America Oncology Drugs Market Share by Type (2017-2028)
6.3 North America Oncology Drugs Market Size by Application
6.3.1 North America Oncology Drugs Market Size by Application (2017-2022)
6.3.2 North America Oncology Drugs Market Size by Application (2023-2028)
6.3.3 North America Oncology Drugs Market Share by Application (2017-2028)
6.4 North America Oncology Drugs Market Size by Country
6.4.1 North America Oncology Drugs Market Size by Country (2017-2022)
6.4.2 North America Oncology Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Oncology Drugs Market Size (2017-2028)
7.2 Europe Oncology Drugs Market Size by Type
7.2.1 Europe Oncology Drugs Market Size by Type (2017-2022)
7.2.2 Europe Oncology Drugs Market Size by Type (2023-2028)
7.2.3 Europe Oncology Drugs Market Share by Type (2017-2028)
7.3 Europe Oncology Drugs Market Size by Application
7.3.1 Europe Oncology Drugs Market Size by Application (2017-2022)
7.3.2 Europe Oncology Drugs Market Size by Application (2023-2028)
7.3.3 Europe Oncology Drugs Market Share by Application (2017-2028)
7.4 Europe Oncology Drugs Market Size by Country
7.4.1 Europe Oncology Drugs Market Size by Country (2017-2022)
7.4.2 Europe Oncology Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Oncology Drugs Market Size (2017-2028)
8.2 Asia-Pacific Oncology Drugs Market Size by Type
8.2.1 Asia-Pacific Oncology Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Oncology Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Oncology Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Oncology Drugs Market Size by Application
8.3.1 Asia-Pacific Oncology Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Oncology Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Oncology Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Oncology Drugs Market Size by Region
8.4.1 Asia-Pacific Oncology Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Oncology Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Oncology Drugs Market Size (2017-2028)
9.2 Latin America Oncology Drugs Market Size by Type
9.2.1 Latin America Oncology Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Oncology Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Oncology Drugs Market Share by Type (2017-2028)
9.3 Latin America Oncology Drugs Market Size by Application
9.3.1 Latin America Oncology Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Oncology Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Oncology Drugs Market Share by Application (2017-2028)
9.4 Latin America Oncology Drugs Market Size by Country
9.4.1 Latin America Oncology Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Oncology Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Oncology Drugs Market Size (2017-2028)
10.2 Middle East & Africa Oncology Drugs Market Size by Type
10.2.1 Middle East & Africa Oncology Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Oncology Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Oncology Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Oncology Drugs Market Size by Application
10.3.1 Middle East & Africa Oncology Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Oncology Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Oncology Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Oncology Drugs Market Size by Country
10.4.1 Middle East & Africa Oncology Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Oncology Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Oncology Drugs Introduction
11.1.4 Roche Revenue in Oncology Drugs Business (2017-2022)
11.1.5 Roche Recent Developments
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Oncology Drugs Introduction
11.2.4 Celgene Revenue in Oncology Drugs Business (2017-2022)
11.2.5 Celgene Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Oncology Drugs Introduction
11.3.4 Novartis Revenue in Oncology Drugs Business (2017-2022)
11.3.5 Novartis Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Oncology Drugs Introduction
11.4.4 Bristol-Myers Squibb Revenue in Oncology Drugs Business (2017-2022)
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Oncology Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Oncology Drugs Business (2017-2022)
11.5.5 Johnson & Johnson Recent Developments
11.6 Merck & Co.
11.6.1 Merck & Co. Company Details
11.6.2 Merck & Co. Business Overview
11.6.3 Merck & Co. Oncology Drugs Introduction
11.6.4 Merck & Co. Revenue in Oncology Drugs Business (2017-2022)
11.6.5 Merck & Co. Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Oncology Drugs Introduction
11.7.4 AstraZeneca Revenue in Oncology Drugs Business (2017-2022)
11.7.5 AstraZeneca Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Oncology Drugs Introduction
11.8.4 Pfizer Revenue in Oncology Drugs Business (2017-2022)
11.8.5 Pfizer Recent Developments
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Oncology Drugs Introduction
11.9.4 Amgen Revenue in Oncology Drugs Business (2017-2022)
11.9.5 Amgen Recent Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Oncology Drugs Introduction
11.10.4 Eli Lilly Revenue in Oncology Drugs Business (2017-2022)
11.10.5 Eli Lilly Recent Developments
11.11 AbbVie
11.11.1 AbbVie Company Details
11.11.2 AbbVie Business Overview
11.11.3 AbbVie Oncology Drugs Introduction
11.11.4 AbbVie Revenue in Oncology Drugs Business (2017-2022)
11.11.5 AbbVie Recent Developments
11.12 Takeda
11.12.1 Takeda Company Details
11.12.2 Takeda Business Overview
11.12.3 Takeda Oncology Drugs Introduction
11.12.4 Takeda Revenue in Oncology Drugs Business (2017-2022)
11.12.5 Takeda Recent Developments
11.13 Astellas
11.13.1 Astellas Company Details
11.13.2 Astellas Business Overview
11.13.3 Astellas Oncology Drugs Introduction
11.13.4 Astellas Revenue in Oncology Drugs Business (2017-2022)
11.13.5 Astellas Recent Developments
11.14 Ipsen
11.14.1 Ipsen Company Details
11.14.2 Ipsen Business Overview
11.14.3 Ipsen Oncology Drugs Introduction
11.14.4 Ipsen Revenue in Oncology Drugs Business (2017-2022)
11.14.5 Ipsen Recent Developments
11.15 Sanofi
11.15.1 Sanofi Company Details
11.15.2 Sanofi Business Overview
11.15.3 Sanofi Oncology Drugs Introduction
11.15.4 Sanofi Revenue in Oncology Drugs Business (2017-2022)
11.15.5 Sanofi Recent Developments
11.16 Bayer
11.16.1 Bayer Company Details
11.16.2 Bayer Business Overview
11.16.3 Bayer Oncology Drugs Introduction
11.16.4 Bayer Revenue in Oncology Drugs Business (2017-2022)
11.16.5 Bayer Recent Developments
11.17 Biogen Idec
11.17.1 Biogen Idec Company Details
11.17.2 Biogen Idec Business Overview
11.17.3 Biogen Idec Oncology Drugs Introduction
11.17.4 Biogen Idec Revenue in Oncology Drugs Business (2017-2022)
11.17.5 Biogen Idec Recent Developments
11.18 Teva
11.18.1 Teva Company Details
11.18.2 Teva Business Overview
11.18.3 Teva Oncology Drugs Introduction
11.18.4 Teva Revenue in Oncology Drugs Business (2017-2022)
11.18.5 Teva Recent Developments
11.19 Otsuka
11.19.1 Otsuka Company Details
11.19.2 Otsuka Business Overview
11.19.3 Otsuka Oncology Drugs Introduction
11.19.4 Otsuka Revenue in Oncology Drugs Business (2017-2022)
11.19.5 Otsuka Recent Developments
11.20 Eisai
11.20.1 Eisai Company Details
11.20.2 Eisai Business Overview
11.20.3 Eisai Oncology Drugs Introduction
11.20.4 Eisai Revenue in Oncology Drugs Business (2017-2022)
11.20.5 Eisai Recent Developments
11.21 Merck KGaA
11.21.1 Merck KGaA Company Details
11.21.2 Merck KGaA Business Overview
11.21.3 Merck KGaA Oncology Drugs Introduction
11.21.4 Merck KGaA Revenue in Oncology Drugs Business (2017-2022)
11.21.5 Merck KGaA Recent Developments
11.22 Gilead Sciences
11.22.1 Gilead Sciences Company Details
11.22.2 Gilead Sciences Business Overview
11.22.3 Gilead Sciences Oncology Drugs Introduction
11.22.4 Gilead Sciences Revenue in Oncology Drugs Business (2017-2022)
11.22.5 Gilead Sciences Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
